Income Statement
GREENWICH LIFESCIENCES, INC.
GLSI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
16.01 | 9.33 | 8.04 | 4.60 | 1.86 |
|
Research & Development
|
12.95 | 7.70 | 6.48 | 3.56 | 1.06 |
|
Selling, General & Administrative
|
3.06 | 1.63 | 1.56 | 1.04 | 0.81 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-16.01 | -9.33 | -8.04 | -4.60 | -1.86 |
|
Non-Operating Income
|
- | - | - | - | - |
|
Interest Income
|
0.22 | 0.44 | 0.22 | 0.03 | 0.00 |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-15.79 | -8.89 | -7.83 | -4.57 | -1.86 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-16.01 | -9.33 | -8.04 | -4.60 | -1.86 |
|
Earnings Per Share (Basic)
|
-1.21 | -0.69 | -0.61 | - | - |
|
Diluted EPS
|
-1.21 | -0.69 | - | - | - |
|
Weighted Average Shares
|
13.01 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
13.01 | 12.85 | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - |